The proteasome inhibitor PS-341 sensitizes neoplastic cells to TRAIL-mediated apoptosis by reducing levels of c-FLIP

Thomas J. Sayers*, Alan D. Brooks, Crystal Y. Koh, Weihong Ma, Naoko Seki, Arati Raziuddin, Bruce R. Blazar, Xia Zhang, Peter J. Elliott, William J. Murphy

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

205 Citations (Scopus)

Fingerprint Dive into the research topics of 'The proteasome inhibitor PS-341 sensitizes neoplastic cells to TRAIL-mediated apoptosis by reducing levels of c-FLIP'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences